PENTA-ID

what's new

The ZIKAction Kick-Off Meeting was a success!

The ZIKAction Kick-Off Meeting was held in Kingston, Jamaica at the University of West Indies from October 30th to November 1st.

Thank you all...

PENTA Foundation coordinated ZIKAction consortium awarded €7 million EU H2020 grant to combat Zika virus and other emerging infectious disease outbreaks

The ZIKAction consortium (Preparedness, research and action network on maternal-paediatric axis of Zika virus infection in Latin America and the...

First patient enrolled in PED-MERMAIDS study

We are glad to announce that the first patient was enrolled in the PED-MERMAIDS study by the clinical team in Madrid, Spain.

First patient enrolled in ODYSSEY study

We are happy to announce that the first patient was enrolled in the ODYSSEY study by the team in Zimbabwe.

We encourage all the sites to follow.

 

Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV

The paper: Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV is now published.

Click 

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial is now published

The paper: Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial is now published.

Click

The 1st patient was screened in SMILE in Spain

We are happy to announce that the first patient was screened in SMILE in Spain. We encourage all the sites to follow.

PENPACT1 paper was cited as a basis for changing U.S. Department of Health and Human Services guidelines on pediatric antiretroviral therapy

The PENPACT1 paper titled "Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation" was cited (along with the adult START trial) as a basis for changing U.S. Department of Health and Human Services guidelines on pediatric antiretroviral...

The Article Children and young people with perinatal HIV in Europe: Epidemiological situation in 2014 and implications for the future is out

The Article "Children and young people with perinatal HIV in Europe: Epidemiological situation in 2014 and implications for the future" is out.

Click here to...

PED-MERMAIDS Study Protocol approved in Spain

We are glad to inform you that the protocol of PED-MERMAIDS study has received the first Ethics approval in Spain.
The PENTA Foundation is the sponsor of the study, which is financed by the European Union 7th Framework Programme within the project PREPARE.